To register and apply for Class I IVD (In Vitro Diagnostic) medical device registration under Hong Kong’s Medical Device Administrative Control System (MDACS), you need to submit the application and required documentation to the Medical Device Division (MDD) of the Department of Health in Hong Kong.

The cost and time required for Class I IVD medical device registration under Hong Kong’s Medical Device Administrative Control System (MDACS) can vary based on the specifics of the device and the completeness of the application.

For Class I IVD (In Vitro Diagnostic) medical device registration under Hong Kong's Medical Device Administrative Control System (MDACS), the Department of Health’s Medical Device Division (MDD) has outlined specific requirements to ensure that low-risk devices meet safety, performance, and quality standards.

Class I IVD (in vitro diagnostic) medical device registration in Hong Kong under the Medical Device Administrative Control System (MDACS) is a voluntary process, intended to ensure that low-risk IVD devices meet safety, quality, and performance standards. This registration is handled by the Department of Health’s Medical Device Division (MDD).

In Hong Kong, Class I IVD (In Vitro Diagnostic) medical devices are those considered to be low-risk under the Medical Device Administrative Control System (MDACS), overseen by the Department of Health’s Medical Device Division (MDD). The MDACS system provides a structured process to ensure the safety, quality, and performance of medical devices before they can be marketed.

Applying for Class I IVD (in vitro diagnostic) medical device registration in Hong Kong under the Medical Device Administrative Control System (MDACS) is relatively streamlined. Class I devices are considered low-risk, so they generally follow simpler procedures compared to higher-risk categories.

The time to obtain Class I medical device registration with ANVISA in Brazil typically takes around 1 to 3 months. However, the specific timeline can vary based on several factors, including the completeness of your application and the workload of ANVISA.

No, Class I medical device registration with ANVISA in Brazil does not require annual reviews. However, once registered, the device must be maintained in compliance with ANVISA's regulations and subject to post-market surveillance.